These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1069 related items for PubMed ID: 15205322

  • 1. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M, Wu K, Fu M, Rao M, Albanese C, Russell RG, Lian H, Bregman D, White MA, Pestell RG.
    Cancer Res; 2004 Jun 15; 64(12):4122-30. PubMed ID: 15205322
    [Abstract] [Full Text] [Related]

  • 2. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
    D'Amico M, Wu K, Di Vizio D, Reutens AT, Stahl M, Fu M, Albanese C, Russell RG, Muller WJ, White M, Negassa A, Lee HW, DePinho RA, Pestell RG.
    Cancer Res; 2003 Jun 15; 63(12):3395-402. PubMed ID: 12810676
    [Abstract] [Full Text] [Related]

  • 3. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY, Chen TC, Hung SP, Chen MF, Yeh CT, Tsai SL, Chu CM, Liaw YF.
    Anticancer Res; 2002 Jun 15; 22(2B):1265-71. PubMed ID: 12168936
    [Abstract] [Full Text] [Related]

  • 4. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A, Busse C, Weinans L, Benicke M, Katalinic A, Geissler F, Hauss J, Wittekind C.
    Oncogene; 2001 Oct 25; 20(48):7104-9. PubMed ID: 11704835
    [Abstract] [Full Text] [Related]

  • 5. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P, Schmidt M, Hu X, Wolff L.
    Oncogene; 2003 Mar 20; 22(11):1600-10. PubMed ID: 12642863
    [Abstract] [Full Text] [Related]

  • 6. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
    Weber A, Langhanki L, Schütz A, Wittekind C, Bootz F, Tannapfel A.
    J Pathol; 2002 Nov 20; 198(3):326-34. PubMed ID: 12375265
    [Abstract] [Full Text] [Related]

  • 7. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE, Ramsey MR, Balasubramanian P, Castrillon DH, DePinho RA.
    Oncogene; 2004 Jan 15; 23(2):379-85. PubMed ID: 14724566
    [Abstract] [Full Text] [Related]

  • 8. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
    Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A.
    Virchows Arch; 2002 Aug 15; 441(2):133-42. PubMed ID: 12189502
    [Abstract] [Full Text] [Related]

  • 9. One INK4 gene and no ARF at the Fugu equivalent of the human INK4A/ARF/INK4B tumour suppressor locus.
    Gilley J, Fried M.
    Oncogene; 2001 Nov 01; 20(50):7447-52. PubMed ID: 11704876
    [Abstract] [Full Text] [Related]

  • 10. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H, Enomoto T, Ueda Y, Fujita M, Nakashima R, Ueno Y, Miyatake T, Yoshizaki T, Buzard GS, Kimura T, Yoshino K, Murata Y.
    Cancer Lett; 2004 Sep 15; 213(1):31-7. PubMed ID: 15312681
    [Abstract] [Full Text] [Related]

  • 11. Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution.
    Gadd M, Pisc C, Branda J, Ionescu-Tiba V, Nikolic Z, Yang C, Wang T, Shackleford GM, Cardiff RD, Schmidt EV.
    Cancer Res; 2001 Dec 15; 61(24):8811-9. PubMed ID: 11751403
    [Abstract] [Full Text] [Related]

  • 12. p14ARF protein expression is a predictor of both relapse and survival in squamous cell carcinoma of the anterior tongue.
    Kwong RA, Kalish LH, Nguyen TV, Kench JG, Bova RJ, Cole IE, Musgrove EA, Sutherland RL.
    Clin Cancer Res; 2005 Jun 01; 11(11):4107-16. PubMed ID: 15930346
    [Abstract] [Full Text] [Related]

  • 13. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
    Edmunds SC, Kelsell DP, Hungerford JL, Cree IA.
    Invest Ophthalmol Vis Sci; 2002 Sep 01; 43(9):2845-51. PubMed ID: 12202501
    [Abstract] [Full Text] [Related]

  • 14. Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.
    Tannapfel A, Sommerer F, Benicke M, Weinans L, Katalinic A, Geissler F, Uhlmann D, Hauss J, Wittekind C.
    J Pathol; 2002 Aug 01; 197(5):624-31. PubMed ID: 12210082
    [Abstract] [Full Text] [Related]

  • 15. p16INK4a and p14ARF methylation as a potential biomarker for human bladder cancer.
    Kawamoto K, Enokida H, Gotanda T, Kubo H, Nishiyama K, Kawahara M, Nakagawa M.
    Biochem Biophys Res Commun; 2006 Jan 20; 339(3):790-6. PubMed ID: 16316628
    [Abstract] [Full Text] [Related]

  • 16. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
    Floyd HS, Jennings-Gee JE, Kock ND, Miller MS.
    Mol Carcinog; 2006 Jul 20; 45(7):506-17. PubMed ID: 16482519
    [Abstract] [Full Text] [Related]

  • 17. Differential roles of p16INK4A and p14ARF genes in prognosis of oral carcinoma.
    Sailasree R, Abhilash A, Sathyan KM, Nalinakumari KR, Thomas S, Kannan S.
    Cancer Epidemiol Biomarkers Prev; 2008 Feb 20; 17(2):414-20. PubMed ID: 18268126
    [Abstract] [Full Text] [Related]

  • 18. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ, Bertwistle D, DEN Besten W, Kuo ML, Sugimoto M, Tago K, Williams RT, Zindy F, Roussel MF.
    Cold Spring Harb Symp Quant Biol; 2005 Feb 20; 70():129-37. PubMed ID: 16869746
    [Abstract] [Full Text] [Related]

  • 19. The co-transfection of p16(INK4a) and p14(ARF) genes into human lung cancer cell line A549 and the effects on cell growth and chemosensitivity.
    Xie QC, Hu YD, Wang LL, Chen ZT, Diao XW, Wang ZX, Guan HJ, Zhu B, Sun JG, Duan YZ, Chen FL, Nian WQ.
    Colloids Surf B Biointerfaces; 2005 Dec 20; 46(3):188-96. PubMed ID: 16337111
    [Abstract] [Full Text] [Related]

  • 20. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression.
    Vonlanthen S, Heighway J, Tschan MP, Borner MM, Altermatt HJ, Kappeler A, Tobler A, Fey MF, Thatcher N, Yarbrough WG, Betticher DC.
    Oncogene; 1998 Nov 26; 17(21):2779-85. PubMed ID: 9840942
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 54.